Human monoclonal antibodies against Hendra and Nipah viruses

Details Human monoclonal antibodies against Hendra and Nipah viruses Human monoclonal antibodies against Hendra and Nipah viruses

2011-08-02

2011-08-02

Lucas, Zachariah (Department: 1648)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Monoclonal antibody or fragment thereof

C424S130100, C424S141100, C424S159100, C424S204100, C424S211100, C530S387100, C530S388100, C530S388200, C530S388300

Reexamination Certificate

active

07988971

ABSTRACT:
The present invention relates to monoclonal antibodies that bind or neutralize Hendra or Nipah virus. The invention provides such antibodies, fragments of such antibodies retaining Hendra or Nipah virus-binding ability, fully human antibodies retaining Hendra or Nipah virus-binding ability, and pharmaceutical compositions including such antibodies. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. Additionally, the invention provides for prophylactic, therapeutic, and diagnostic methods employing the antibodies and nucleic acids of the invention.

REFERENCES:
patent: WO94/09136 (1994-04-01), None
patent: WO 03/057824 (2003-07-01), None
patent: WO 2005/028673 (2005-03-01), None
Vajdos et al., Comprehensive Functional Maps of the Antigen binding Site of an Anti-ErbB2 Antibody Obtained with Shotgun Scanning Mutagenesis, 2002, Journal of Molecular Biology, vol. 320, pp. 415-428.
Zhu et al., Exceptionally Potent Cross-Reactive Neutralization of Nipah and Hendra Viruses by a Human Monoclonal Antibody, 2008, Journal of Infectious Diseases, vol. 197, pp. 846-853.
Bonaparte et al. (2005), Ephrin-B2 Ligand is a Functional Receptor for Hendra virus and Nipah Virus. PNAS 102:10652-10657.
Bossart et al. (2002). Membrane Fusion Tropism and Heterotypic Functional Activities of the Nipah Virus and Hendra Virus Envelope Glycoproteins. J. Virol. 6:11186-11198.
Bossart et al. (2001). Functional Expression and Membrane Fusion Tropism of the Envelope Glycoproteins of Hendra Virus. Virology 290: 121-135.
Bossart et al. (2003). Nipah and Hendra Virus Fusion, Entry and its Inhibition. J. Clin. Virol. 28(S1)S40:L2-L3.
Butler, D. (2004). Fatal Fruit Bat Virus Sparks Epidemic in Southern Asia. Nature 429:7.
Chew et al. (2000). Risk Factors for Nipah Virus Infection Among Abattoir Workers in Singapore. J. Infect. Dis. 181:1760-1763.
Chua et al. (2000). High Mortality in Nipah Encephalitis Is Associated with Presence of Virus in Cerebrospinal Fluid. Ann. Neurol. 48:802-805.
Crameri et al. (2002). A Rapid Immune Plaque Assay for the Detection of Hendra and Nipah Viruses and Anti-Virus Antibodies. J. Virol. Methods 99:41-51.
Dimitrov, D. (2004). Virus Entry: Molecular Mechanism and Biomedical Applications. Nature Reviews Microbiology 2: 109-122.
Eaton, B. T. (2001). Introduction to Current Focus on Hendra and Nipah Viruses. Microbes Infect. 3:277-278.
Enserink, M. (2004). Nipah Virus (or a Cousin) Strikes Again. Science 303:1121.
Field et al. (2001). The Natural History of Hendra and Nipah Viruses. Microbes Infect. 3:307-314.
Goh et al. (2000). Clinical Features of Nipah Virus Encephalitis Among Pig Farmers in Malaysia. N. Engl. J. Med. 342:1229-1235.
Guillaume et al. (2004). Nipah virus: Vaccination and passive protection studies in a hamster model. J. Virol. 78: 834-840.
Harcourt et al. (2000). Molecular Characterization of Nipah Virus, a Newly Emergent Paramyxovirus. Virology 271: 334-349.
Hooper et al. (2001). Comparative Pathology of the Disease Caused by Hendra and Nipah Viruses. Microbes Infect. 3:315-322.
Hsu et al. (2004). Nipah Virus Encephalitis Reemergence, Bangladesh. Emerg. Infect. Dis. 10:2082-2087.
Lamb et al. (2001). Paramyxoviridae: The Viruses and their Replication, inFields Virology, eds. Knippe, D. M. & Howley, P. M., Lippincott Williams & Wilkins, Philadelphia, pp. 1305-1340.
Lee et al. (1999). The Neurological Manifestations of Nipah Virus Encephalitis, a Novel Paramyxovirus. Ann. Neurol. 46:428-432.
Lim et al. (2000). Nipah Viral Encephalitis or Japanese Encephalitis? MR Findings in New Zoonotic Disease. Am. J. Neuroradiol. 21:455-461.
Mourland et al. (2002). Novel Broadly Cross-reactive HIV-1 Neutralizing Human Monoclonal Fab Selected for Binding to gp120-CD4-CCR-5 Complexes. Proc. Natl. Acad. Sci. USA 99: 6913-6918.
Murray et al. (1995). A Morbillivirus That Caused Fatal Disease in Horses and Humans. Science 268: 94-97.
Tamin et al. (2002). Functional Properties of the Fusion and Attachment Glycoproteins of Nipah Virus. Virology 296: 190-200.
Unknown Author (2004). Nipah Encephalitis Outbreak Over Wide Area of Western Bangladesh, 2004. Health and Science Bulletin (ICDDR,B) 2:5-9.
Unknown Author (2004). Nipah Virus Outbreak(s) in Bangladesh, Jan.-Apr. 2004. Wkly Epidimal Rece. 79: 168-171.
Ward, J. W. ed. (1999). Update: Outbreak of Nipah Virus—Malaysia and Singapore, 1999. Morb. Morta.I Wkly. Rep. 48:335-337.
Yu et al. (1998). The Attachment Protein of Hendra Virus Has High Structural Similarity but Limited Primary Sequence Homology Compared with Viruses in the Genus Paramyxovirus. Virology 251:227-233.
Zhang et al. (2004). Improved Breadth and Potency of HIV-1-Neutralizing Human Single-Chain Antibody by Random Mutagenesis and Sequential Antigen Panning. J. Mol. Biol. 335: 209-219.

Affiliated with

Also associated with

Rating

Human monoclonal antibodies against Hendra and Nipah viruses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human monoclonal antibodies against Hendra and Nipah viruses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human monoclonal antibodies against Hendra and Nipah viruses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2626771